Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial

Alexandre B Cavalcanti, Fernando G Zampieri, Luciano CP Azevedo, Regis Rosa, Álvaro Avezum, Viviane C Veiga, Renato D. Lopes, Letícia Kawano-Dourado, Lucas P Damiani, Adriano J Pereira, Ary Serpa-Neto, Remo Furtado, Bruno Tomazini, Fernando A Bozza, Israel S. Maia, Maicon Falavigna, Thiago C Lisboa, Henrique Fonseca, Flávia R Machado, Otavio Berwanger, for the COALITION COVID-19 Brasil I Investigators
doi: https://doi.org/10.1101/2020.05.19.20106997

Data Availability

This is a protocol paper. No data is provided.

Back to top
Posted May 26, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial
Alexandre B Cavalcanti, Fernando G Zampieri, Luciano CP Azevedo, Regis Rosa, Álvaro Avezum, Viviane C Veiga, Renato D. Lopes, Letícia Kawano-Dourado, Lucas P Damiani, Adriano J Pereira, Ary Serpa-Neto, Remo Furtado, Bruno Tomazini, Fernando A Bozza, Israel S. Maia, Maicon Falavigna, Thiago C Lisboa, Henrique Fonseca, Flávia R Machado, Otavio Berwanger, for the COALITION COVID-19 Brasil I Investigators
medRxiv 2020.05.19.20106997; doi: https://doi.org/10.1101/2020.05.19.20106997
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area